<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-124
Date of Submission: 2024-10-31

This report was submitted by a Patient from Rowe Inc Medical Center concerning patient ANON-PX-4154. The subject is a 69-year-old male with a significant medical history including chronic kidney disease, coronary artery disease, osteoarthritis, seasonal allergies. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Amoxicillin (Penicillin antibiotic) administered via the Intravenous route at a dosage of 51mg, initiated on 2024-09-27 for Bacterial infection and discontinued on 2024-10-19.

On approximately 2024-10-09, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Pruritus, Vomiting, Somnolence. The Pruritus was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. The Vomiting was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. The Somnolence was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed federal and advised late. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

</data>
report_id: ADR-2024-124
report_date: '2024-10-31'
patient_details:
  patient_id: ANON-PX-4154
  gender: Male
  relevant_history:
  - chronic kidney disease
  - coronary artery disease
  - osteoarthritis
  - seasonal allergies
  age_at_reaction: 69
suspected_drugs:
- drug_name: Amoxicillin
  dosage: 51mg
  route_of_administration: Intravenous
  start_date: '2024-09-27'
  indication_for_use: Bacterial infection
  drug_class: Penicillin antibiotic
  end_date: '2024-10-19'
adverse_reactions:
- symptom_name: Pruritus
  onset_date: '2024-10-09'
  severity: Mild
  outcome: Recovering
  intervention_required: false
- symptom_name: Vomiting
  onset_date: '2024-10-09'
  severity: Severe
  outcome: Recovered
  intervention_required: false
- symptom_name: Somnolence
  onset_date: '2024-10-09'
  severity: Mild
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed federal and advised late.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
reporting_facility: Rowe Inc Medical Center
reporter_type: Patient
